Get started
Author

R. D. Syubaev

Development of Paediatric Medicines: Key Risk Factors and Non-clinical Research Programmes
2023 · G. N. Engalycheva, R. D. Syubaev · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 36
PDF
Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies
2020 · O, A. Bezborodova, A. A. Pankratov, et al. · Ведомости Научного центра экспертизы средств медицинского применения · 7
PDF
Relevant Species Selection for Preclinical Safety Studies of Medicines: A Review
2025 · G. N. Engalycheva, R. D. Syubaev · Safety and Risk of Pharmacotherapy · 6
PDF
Quality Standards of Preclinical Pharmacological Studies
2019 · G, N. Engalycheva, R. D, Syubaev, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 6
WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review
2024 · G. N. Engalycheva, R. D. Syubaev · Safety and Risk of Pharmacotherapy · 5
PDF
Mathematical Prediction of the Efficacy of Medicinal Products in Preclinical Studies
2022 · O. V. Shreder, N. D. Bunyatyan, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 5
PDF
High Dose Selection for General Toxicity Studies of New Medicines
2023 · G. N. Engalycheva, R. D. Subaev · Safety and Risk of Pharmacotherapy · 4
PDF
Preparation of a Nonclinical Overview Based on Scientific Literature
2021 · G. N. Engalycheva, R. D. Syubaev · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 1
Expert Evaluation of Preclinical Studies of Primary and Secondary Pharmacodynamics of Medicines
2018 · G. N. Engalycheva, R. D. Subaev, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 1
PDF
Oligonucleotide-based medicinal products: A review of current regulatory requirements for preclinical studies
2026 · G. N. Engalycheva, R. D. Syubaev, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Preclinical Studies of Modern Radiopharmaceuticals: Expert Approaches to Evaluating the Results
2025 · G. N. Engalycheva, R. D. Syubaev, et al. · Safety and Risk of Pharmacotherapy
Predicting the Relative Risk of Pharmacotherapy Based on a Mathematical Model of Age-Related Decline in Homeostasis in Elderly and Senile Patients
2025 · R. D. Syubaev, G. N. Engalycheva · Safety and Risk of Pharmacotherapy
Preclinical safety studies of medicines in the Eurasian economic union
2025 · G. N. Engalycheva, R. D. Syubaev, et al. · Pharmacokinetics and Pharmacodynamics
PDF
Justification of Safety of Homeopathic Medicines in a Registration Dossier
2019 · R. D. Subaev, G. N. Engalycheva, et al. · Safety and Risk of Pharmacotherapy
PDF
Works count: 14
Citation count: 71
H-index: 5
I10-index: 1
Year
Topic
Type